Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

797 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Among authors: reuter s. Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17. Lancet Infect Dis. 2024. PMID: 38244557 Clinical Trial.
Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ, Fätkenheuer G, Prinz-Langenohl R, Paulus U, Hellmich M, Weiß V, Jung N, Rieg S, Kern WV, Seifert H; SABATO trial group (with linked authorship to the individuals in the Acknowledgements section). Kaasch AJ, et al. Trials. 2015 Oct 9;16:450. doi: 10.1186/s13063-015-0973-x. Trials. 2015. PMID: 26452342 Free PMC article. Clinical Trial.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
Dynamic two-dimensional covalent organic frameworks.
Auras F, Ascherl L, Bon V, Vornholt SM, Krause S, Döblinger M, Bessinger D, Reuter S, Chapman KW, Kaskel S, Friend RH, Bein T. Auras F, et al. Among authors: reuter s. Nat Chem. 2024 May 3. doi: 10.1038/s41557-024-01527-8. Online ahead of print. Nat Chem. 2024. PMID: 38702406
Olfactory receptors impact pathophysiological processes of lung diseases in bronchial epithelial cells.
Weidinger D, Jacobsen J, Alisch D, Uebner H, Heinen N, Greune L, Westhoven S, Jamal Jameel K, Kronsbein J, Pfaender S, Taube C, Reuter S, Peters M, Hatt H, Knobloch J. Weidinger D, et al. Among authors: reuter s. Eur J Cell Biol. 2024 Mar 30;103(2):151408. doi: 10.1016/j.ejcb.2024.151408. Online ahead of print. Eur J Cell Biol. 2024. PMID: 38583306 Free article.
Education, employment, and income among people living with cystic fibrosis across three decades - A matched cohort study using Danish health registries.
Jensen CB, Jensen KJ, Pressler T, Katzenstein TL, Skov M, Qvist T, Olsen MF, Jeppesen M, Jensen-Fangel S, Olesen HV, Reuter SB, Pedersen HKR, Wang JN, Michalopoulos S, McGarry L, Wöhling H, Petersen J, Jimenez-Solem E; TransformCF study group. Jensen CB, et al. Among authors: reuter sb. J Cyst Fibros. 2024 Mar 14:S1569-1993(24)00039-0. doi: 10.1016/j.jcf.2024.03.009. Online ahead of print. J Cyst Fibros. 2024. PMID: 38485602
797 results